Home > Insider Trading > Filing (0001209191-17-025577)

Filing Details

Accession Number:: 0001209191-17-025577
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-05 16:06:21
Reporting Period:: 2017-04-03

Filing Date:: 2017-04-05
Accepted Time:: 2017-04-05 16:06:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488613	Foundation Medicine Inc.	FMI	Services-Medical Laboratories (8071)	271316416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1584999	A. Vincent Miller	150 Second Street C/O Foundation Medicine, Inc. Cambridge MA 02141	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-03-13	1,000	$32.70	105,139	No	5	G	Direct
Common Stock	Disposition	2017-04-03	257	$31.96	104,882	No	4	S	Direct
Common Stock	Disposition	2017-04-03	1,096	$31.96	103,786	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	G	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on March 31, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
The reporting person previously reported restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event on March 31, 2017.
Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event on April 1, 2017.